13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001856083
申报总市值
US$68.7亿
US$68.7亿
65 檔
13.8%
Deep Track Capital, LP 在 Q2 2025 季度的美股仓位总计估值为 US$68.7亿，分散于 65 个持仓标的之中，反映其市场参与广度与投资规模。
Deep Track Capital, LP 在 Q2 2025 进行了结构性的板块轮动与仓位换股。在开立 7 个全新仓位及加仓 18 档持股的同时，亦同步清仓 11 档并减仓 20 档标的。
在资产配置集中度方面，Deep Track Capital, LP 的前 5 大核心持股（包含 GH, IONS, PTGX 等）合计占整体申报市值的 13.8%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | GH | Guardant Health Inc | 股票-医疗保健 | 7.09% | +2.37% | -21.93% | |
| 2 | IONS | Ionis Pharmaceuticals Inc | 股票-医疗保健 | 6.20% | +0.15% | +7.17% | |
| 3 | PTGX | Protagonist Therapeutics Inc | 股票-其他 | 5.75% | — | +8.20% | |
| 4 | DVAX | Dynavax Technologies CORP | 股票-其他 | 5.66% | — | — | |
| 5 | INSM | Insmed Inc | 股票-医疗保健 | 5.65% | — | +586.95% | |
| 6 | AKRO | Akero Therapeutics Inc | 股票-其他 | 5.21% | — | -5.22% | |
| 7 | IMVT | Immunovant Inc | 股票-其他 | 4.87% | +0.56% | — | |
| 8 | OCUL | Ocular Therapeutix Inc | 股票-其他 | 4.25% | +0.09% | — | |
| 9 | APLSUSD | Apellis Pharmaceuticals Inc | 股票-其他 | 3.89% | -2.98% | EXIT | |
| 10 | CYTK | Cytokinetics Inc | 股票-医疗保健 | 3.87% | -0.61% | +18.74% | |
| 11 | GPCR | Structure Therapeutics Inc | 股票-其他 | 3.41% | +0.33% | +25.22% | |
| 12 | ETNBGBP | 89bio Inc | 股票-其他 | 2.99% | — | +1.97% | |
| 13 | AXSM | Axsome Therapeutics Inc | 股票-医疗保健 | 2.68% | -0.55% | — | |
| 14 | VRDN | Viridian Therapeutics Inc | 股票-其他 | 2.41% | +0.51% | — | |
| 15 | TARS | Tarsus Pharmaceuticals Inc | 股票-其他 | 2.27% | -0.76% | +17.90% | |
| 16 | PCVX | Vaxcyte Inc | 股票-其他 | 2.24% | -0.44% | +186.67% | |
| 17 | NRIX | Nurix Therapeutics Inc | 股票-其他 | 2.22% | +1.12% | +10.27% | |
| 18 | GERN | Geron CORP | 股票-其他 | 1.94% | -0.77% | EXIT | |
| 19 | IMCR | Immunocore Holdings Plc-adr | 股票-其他 | 1.81% | -0.81% | +27.53% | |
| 20 | RARE | Ultragenyx Pharmaceutical In | 股票-其他 | 1.57% | — | — | |
| 21 | MAZE | Maze Therapeutics Inc | 股票-其他 | 1.55% | -0.08% | +20.79% | |
| 22 | ANIP | Ani Pharmaceuticals Inc | 股票-其他 | 1.46% | -0.75% | EXIT | |
| 23 | XENE | Xenon Pharmaceuticals Inc | 股票-其他 | 1.36% | — | +35.00% | |
| 24 | DNTH | Dianthus Therapeutics Inc | 股票-其他 | 1.33% | — | -5.28% | |
| 25 | CLDX | Celldex Therapeutics Inc | 股票-其他 | 1.31% | +0.92% | — | |
| 26 | BBIO | Bridgebio Pharma Inc | 股票-医疗保健 | 1.25% | -1.02% | EXIT | |
| 27 | AUTL | Autolus Therapeutics PLC | 股票-其他 | 1.23% | — | -5.59% | |
| 28 | ✓ | 股票-其他 | 1.00% | — | — | ||
| 29 | 430 | Terns Pharmaceuticals Inc | 股票-其他 | 0.90% | -0.92% | EXIT | |
| 30 | TECX | Tectonic Therapeutic Inc | 股票-其他 | 0.89% | — | — | |
| 31 | ABVX | Abivax Sa-adr | 股票-其他 | 0.85% | — | -2.77% | |
| 32 | JBIO | Jade Biosciences Inc | 股票-其他 | 0.80% | — | — | |
| 33 | MBX | Mbx Biosciences Inc | 股票-其他 | 0.80% | +0.05% | -27.50% | |
| 34 | CMPS | Compass Pathways PLC | 股票-其他 | 0.79% | +1.40% | -0.32% | |
| 35 | GHRS | GH Research PLC | 股票-其他 | 0.78% | +1.30% | NEW | |
| 36 | BCAX | Bicara Therapeutics Inc | 股票-其他 | 0.72% | +0.45% | +21.33% | |
| 37 | ORKA | Oruka Therapeutics Inc | 股票-其他 | 0.69% | +1.04% | +32.82% | |
| 38 | ✓ | Engene Holdings Inc | 股票-其他 | 0.53% | -0.49% | EXIT | |
| 39 | BRD1EUR | Mind Medicine Mindmed Inc | 股票-其他 | 0.52% | — | — | |
| 40 | UPB | Upstream Bio Inc | 股票-其他 | 0.51% | — | -37.26% | |
| 41 | OLMA | Olema Pharmaceuticals Inc | 股票-其他 | 0.47% | +0.27% | NEW | |
| 42 | ✓ | Merus N V | 股票-其他 | 0.46% | — | — | |
| 43 | HELP | Cybin Inc | 股票-其他 | 0.41% | -0.10% | EXIT | |
| 44 | CDTX | Cidara Therapeutics Inc | 股票-其他 | 0.39% | — | — | |
| 45 | SRPT | Sarepta Therapeutics Inc | 股票-医疗保健 | 0.39% | — | -21.11% | |
| 46 | BCYC | Bicycle Therapeutics Plc-adr | 股票-其他 | 0.27% | — | +56.87% | |
| 47 | ✓ | Crescent Biopharma Inc. | 股票-其他 | 0.23% | -0.14% | EXIT | |
| 48 | 260 | Centessa Pharmaceuticals-adr | 股票-其他 | 0.21% | -2.05% | EXIT | |
| 49 | NVAX | Novavax Inc | 股票-医疗保健 | 0.20% | — | -34.23% | |
| 50 | IVVD | Invivyd Inc | 股票-其他 | 0.20% | — | -11.69% |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | INSM | Insmed Inc | +5% | +586.95% | 加仓 |
| 2 | AXSM | Axsome Therapeutics Inc | +2.7% | NEW | 新建仓 |
| 3 | IONS | Ionis Pharmaceuticals Inc | +1.7% | +7.17% | 加仓 |
| 4 | PCVX | Vaxcyte Inc | +1.3% | +186.67% | 加仓 |
| 5 | GPCR | Structure Therapeutics Inc | +1.1% | +25.22% | 加仓 |
| 6 | PTGX | Protagonist Therapeutics Inc | +1.1% | +8.20% | 加仓 |
| 7 | AKRO | Akero Therapeutics Inc | +1% | -5.22% | 减仓 |
| 8 | OCUL | Ocular Therapeutix Inc | +0.9% | — | 不变 |
| 9 | ETNBGBP | 89bio Inc | +0.8% | +1.97% | 加仓 |
| 10 | JBIO | Jade Biosciences Inc | +0.8% | NEW | 新建仓 |
| 11 | ✓ | Merus N V | +0.5% | NEW | 新建仓 |
| 12 | IMCR | Immunocore Holdings Plc-adr | +0.5% | +27.53% | 加仓 |
| 13 | 430 | Terns Pharmaceuticals Inc | +0.4% | +34.40% | 加仓 |
| 14 | CDTX | Cidara Therapeutics Inc | +0.4% | NEW | 新建仓 |
| 15 | MAZE | Maze Therapeutics Inc | +0.4% | +20.79% | 加仓 |
| 16 | APLSUSD | Apellis Pharmaceuticals Inc | +0.4% | +40.00% | 加仓 |
| 17 | AUTL | Autolus Therapeutics PLC | +0.3% | -5.59% | 减仓 |
| 18 | XENE | Xenon Pharmaceuticals Inc | +0.3% | +35.00% | 加仓 |
| 19 | ✓ | Crescent Biopharma Inc. | +0.2% | NEW | 新建仓 |
| 20 | ORKA | Oruka Therapeutics Inc | +0.2% | +32.82% | 加仓 |
| 21 | 260 | Centessa Pharmaceuticals-adr | +0.2% | NEW | 新建仓 |
| 22 | RAPT | Rapt Therapeutics Inc | +0.2% | NEW | 新建仓 |
| 23 | CLDX | Celldex Therapeutics Inc | +0.1% | — | 不变 |
| 24 | ABVX | Abivax Sa-adr | +0.1% | -2.77% | 减仓 |
| 25 | NRIX | Nurix Therapeutics Inc | +0.1% | +10.27% | 加仓 |
| 26 | HELP | Cybin Inc | +0.1% | — | 不变 |
| 27 | TECX | Tectonic Therapeutic Inc | +0.1% | — | 不变 |
| 28 | MBX | Mbx Biosciences Inc | +0.1% | -27.50% | 减仓 |
| 29 | GHRS | GH Research PLC | +0.1% | — | 不变 |
| 30 | VRDN | Viridian Therapeutics Inc | +0.1% | — | 不变 |
| 31 | BCYC | Bicycle Therapeutics Plc-adr | +0.1% | +56.87% | 加仓 |
| 32 | UPB | Upstream Bio Inc | +0.1% | -37.26% | 减仓 |
| 33 | OLMA | Olema Pharmaceuticals Inc | +0.1% | — | 不变 |
| 34 | BRD1EUR | Mind Medicine Mindmed Inc | +0.1% | — | 不变 |
| 35 | ✓ | 0% | — | 不变 | |
| 36 | CNTX | Context Therapeutics Inc | 0% | — | 不变 |
| 37 | IVVD | Invivyd Inc | 0% | -11.69% | 减仓 |
| 38 | ✓ | Ikena Oncology Inc | 0% | — | 不变 |
| 39 | SYRE | Spyre Therapeutics Inc | — | — | 不变 |
| 40 | CLYM | Climb Bio Inc | — | — | 不变 |
| 41 | RARE | Ultragenyx Pharmaceutical In | 0% | — | 不变 |
| 42 | ALGS | Aligos Therapeutics Inc | 0% | — | 不变 |
| 43 | INO | Inovio Pharmaceuticals Inc | 0% | -36.48% | 减仓 |
| 44 | CMPS | Compass Pathways PLC | 0% | -0.32% | 减仓 |
| 45 | GERN | Geron CORP | 0% | +12.64% | 加仓 |
| 46 | NGNE | Neurogene Inc | 0% | EXIT | 清仓 |
| 47 | ALLKGUSD | Allakos Inc | -0.1% | EXIT | 清仓 |
| 48 | XNCR | Xencor Inc | -0.1% | — | 不变 |
| 49 | DNTH | Dianthus Therapeutics Inc | -0.1% | -5.28% | 减仓 |
| 50 | OKUR | Onkure Therapeutics Inc-a | -0.1% | -65.55% | 减仓 |
根据 SEC 官方 Form 13F 申报备案，Deep Track Capital, LP 在 Q2 2025 季度的美股持仓总市值约为 US$68.7亿，共申报了 65 个公开持股仓位。
在 Q2 2025 季度，Deep Track Capital, LP 按市值排列的前三大核心持股分别为：GH (7.1%)、IONS (6.2%)、PTGX (5.8%)。其中最大持股仓位 GH 占据整体投资组合约 7.1% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
AXSM
市值: US$8365.5万
本季最大获利了结 / 清仓标的
ITCIEUR
前期市值: US$2.6亿
在 Q2 2025 季度中，Deep Track Capital, LP 共进行了 56 项持仓异动，包含新建仓 7 个仓位、加仓 18 个仓位、减仓 20 个仓位以及清仓 11 个仓位。 其中最大新建仓标的为 AXSM。 本季清仓仓位包含 ITCIEUR。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。